A Phase 1 Open-label, Multicenter study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of HBM4003 in Subjects with Advanced Solid Tumors.

  • Haydon, Andrew (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann, (Project Manager)

Project: Research

StatusActive
Effective start/end date10/10/1931/12/24

Keywords

  • Medical Oncology
  • Solid Tumors
  • Clinical trial